In conjunction with Lilly’s recent restructuring initiative, the company has named the leaders of its Development Center of Excellence (CoE) and its five business units: oncology, diabetes, established markets, emerging markets, and Elanco animal health. Tim Garnett, M.D., and Tom Verhoeven, Ph.D., will lead the CoE within Lilly’s Research Laboratories. Dr. Garnett will have responsibility for medical, regulatory, global product safety, translational medicine and global health outcomes. Dr. ...